DE69735417D1 - 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen - Google Patents

2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen

Info

Publication number
DE69735417D1
DE69735417D1 DE69735417T DE69735417T DE69735417D1 DE 69735417 D1 DE69735417 D1 DE 69735417D1 DE 69735417 T DE69735417 T DE 69735417T DE 69735417 T DE69735417 T DE 69735417T DE 69735417 D1 DE69735417 D1 DE 69735417D1
Authority
DE
Germany
Prior art keywords
dihydroxybenzylsulfon
derivatives
treatment
sexual disorders
sexual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69735417T
Other languages
English (en)
Other versions
DE69735417T2 (de
Inventor
Jose Esteve-Soler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9604182A external-priority patent/FR2747040B1/fr
Application filed by Individual filed Critical Individual
Publication of DE69735417D1 publication Critical patent/DE69735417D1/de
Application granted granted Critical
Publication of DE69735417T2 publication Critical patent/DE69735417T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE69735417T 1996-04-03 1997-04-03 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen Expired - Fee Related DE69735417T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9604182A FR2747040B1 (fr) 1996-04-03 1996-04-03 Derives 2,5-dihydroxybenzenesulfoniques comme medicaments pour normaliser la fonction endotheliale et la fonction sexuelle, et traiter les troubles vasculaires d'origine diabetique ou endotheliale
FR9604182 1996-04-03
PCT/EP1997/001709 WO1997037647A1 (fr) 1996-04-03 1997-04-03 Utilisation des derives 2,5-dihydroxybenzenesulfoniques pour la fabrication de medicaments destines a la normalisation de la fonction endotheliale, pour le traitement de la dysfonction sexuelle et des complications vasculaires du diabete, ainsi que des troubles vasculaires d'origine endotheliale

Publications (2)

Publication Number Publication Date
DE69735417D1 true DE69735417D1 (de) 2006-05-04
DE69735417T2 DE69735417T2 (de) 2006-09-21

Family

ID=26070196

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69735417T Expired - Fee Related DE69735417T2 (de) 1996-04-03 1997-04-03 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen

Country Status (9)

Country Link
US (1) US6147112A (de)
EP (1) EP0954298B1 (de)
JP (1) JP2000508308A (de)
AU (1) AU715600B2 (de)
BR (1) BR9708595A (de)
CA (1) CA2251226C (de)
DE (1) DE69735417T2 (de)
NO (1) NO323015B1 (de)
WO (1) WO1997037647A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403643B1 (en) * 1997-04-03 2002-06-11 Laboratories Del Dr. Esteve, S.A. Use of 2,5-dihydroxybenzenesulfonic derivatives for the normalization of endothelial function
ES2180446B1 (es) * 2001-07-02 2004-01-16 Esteve Labor Dr Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
ES2208123A1 (es) * 2002-11-29 2004-06-01 Laboratorios Del Dr. Esteve, S.A. Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
ES2208124B1 (es) * 2002-11-29 2005-10-01 Laboratorios Del Dr. Esteve, S.A. Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
ES2229902B1 (es) * 2003-05-23 2006-06-01 Laboratorios Del Dr. Esteve, S.A. Uso de compuestos 2,5 - dihidroxibencenosulfonicos para la fabricacion de un medicamento.
ES2222831B2 (es) * 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de principio activo que comprende un compuesto 2,5-dihidroxibencenosulfonico y un modulador de los canales de k+.
LT5474B (lt) 2006-04-12 2008-02-25 Laboratorios Del Dr. Esteve, S. A. 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimui
EP2313366A2 (de) 2008-01-03 2011-04-27 Action Medicines, S.L. Verfahren zur herstellung von 2,5-dihydroxybenzolsulfonsäuresalzen
CN110092736A (zh) * 2018-12-05 2019-08-06 湖北广辰药业有限公司 一种减少羟苯双磺酸钙杂质含量的羟苯磺酸钙制备方法
CN110123776A (zh) * 2019-05-17 2019-08-16 贵州天安药业股份有限公司 一种高效微血管循环改善的羟苯磺酸钙胶囊
EP3878837A1 (de) 2020-03-11 2021-09-15 OM Pharma SA 2,5- oder 2,6-disubstituierte-hydrochinon-derivate mit mindestens einer carboxy, sulfo oder amido gruppe verwendbar als arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038390A (en) * 1972-05-17 1977-07-26 Laboratorios Del Dr. Esteve, S.A. Salts of p-dihydroxybenzene disulfonic acids for combatting hemorrhages and fragility of the capillaries
US3947448A (en) * 1972-05-17 1976-03-30 Laboratorios Del Dr. Esteve Sa Salts of novel p-dihydroxybenezene disulfonic acids
AR204506A1 (es) * 1972-05-17 1976-02-12 Esteve Labor Dr Procedimiento de preparacion de sales de acidos p-dihidroxibencenodisulfonicos
US4513007A (en) * 1983-05-03 1985-04-23 Laboratoires Om Sa Method for treating heart disease

Also Published As

Publication number Publication date
EP0954298A1 (de) 1999-11-10
NO984572L (no) 1998-09-30
AU2693697A (en) 1997-10-29
EP0954298B1 (de) 2006-03-08
JP2000508308A (ja) 2000-07-04
WO1997037647A1 (fr) 1997-10-16
CA2251226C (fr) 2007-09-11
NO323015B1 (no) 2006-12-27
BR9708595A (pt) 1999-08-03
US6147112A (en) 2000-11-14
DE69735417T2 (de) 2006-09-21
AU715600B2 (en) 2000-02-03
CA2251226A1 (fr) 1997-10-16
NO984572D0 (no) 1998-09-30

Similar Documents

Publication Publication Date Title
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
ATE269866T1 (de) Intranasale zubereitungen zur behandlung sexueller störungen
DE69925571D1 (de) Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69739303D1 (de) Vorrichtung zur thermischen behandlung von gewebe
DE59712045D1 (de) Vorrichtung zur behandlung des herzens
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
DE69612279D1 (de) Behandlung schwerer aromaten
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69711311D1 (de) Vorrichtung zur thermischen Behandlung von Gewebe
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee